New drug aims to keep COPD patients out of the hospital after a Flare-Up
NCT ID NCT07587658
First seen May 17, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study tests whether adding the drug dupilumab to standard COPD treatment can prevent another serious flare-up after a hospital stay. About 754 adults with COPD who have high levels of certain white blood cells will receive either dupilumab or a placebo for around 90 days. The goal is to see if the drug reduces hospital readmissions, emergency visits, or death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.